TB
Publicaties op Oncologisch.com
Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemoth...
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.
Orale taxaan ModraDoc006/r versus IV docetaxel bij mCRPC: fase II
Lenvatinib plus pembrolizumab versus sunitinib bij mRCC: CLEAR langetermijn